Johnson & Johnson is promoting two of its most senior executives as it prepares to replace William Weldon, its current …

A new online community has been launched to bring together suggestions for improving healthcare and the altruistic side of those …
Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …
Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …
Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …
The healthcare arm of French communications giant Publicis Groupe has bought a German agency specialising in digital health comms to …
MPs have issued a stark warning on the impact of Government spending plans on the England’s health services, saying they …
Bayer HealthCare is ramping up its biologics production capacity with the building of a new facility in Wuppertal, Germany, that …
GlaxoSmithKline has acquired UK sports nutrition firm Maxinutrition for £162 million to help broaden its consumer portfolio. The company already …

Pfizer has suffered a blow to its drug development programme with the withdrawal of pulmonary arterial hypertension (PAH) brand Thelin …
Recalls at Johnson & Johnson are coming thick and fast at the moment. In the latest incident the firm’s troubled …
Bulgarian drugmaker Sopharma says it will press ahead with plans to build a new production plant for oral dosage forms …
Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …

Amgen has met with Actelion to discuss a potential takeover but has not yet made a bid for the Swiss …
Novartis has pulled Zometa’s marketing application for an early breast cancer indication after the drug failed to meet its primary …
China will replace the US as the number one ‘powerhouse of innovation’ within the next ten years according to a …
Bristol-Myers Squibb has appointed Amadou Diarra as general manager of its UK company, where he will be in charge of …
West Pharmaceutical Services has taken the axe to its manufacturing facilities in the US and UK in order to cut …
The Indian bulk drug industry is expected to expand at an annual growth rate of 21% to reach $16.91 billion …
Pfizer has dimissed as “preposterous” the claims it hired investigators to uncover evidence of corruption by a top government official …